Myasthenia gravis (MG) is a rare autoimmune disorder affecting the communication between nerves and muscles, leading to muscle weakness and fatigue1 . It most commonly affects young women under 40 and older men over 60, with symptoms often beginning in the eye muscles2 . Although there is no cure, advances in diagnosis and treatment have significantly improved patient outcomes and quality of life1 3.
Myasthenia Gravis Symptoms
Myasthenia gravis is characterized by fluctuating muscle weakness that worsens with exertion and improves with rest4 . The hallmark symptoms include fatigable weakness affecting ocular, bulbar (throat and facial), and proximal limb muscles5 . In about two-thirds of patients, weakness of the eye muscles is the initial symptom4 .
Common symptoms include:
- Ptosis (drooping eyelids), which may be unilateral or bilateral6
- Diplopia (double vision), often an early sign7
- Difficulty speaking, chewing, swallowing, or breathing due to bulbar and respiratory muscle weakness8 9
- Weakness in the arms, legs, and neck muscles, often worsening throughout the day1 10
- Fluctuation in symptom severity, with symptoms typically worse at the end of the day or after activity11 10
Respiratory muscle involvement can lead to dyspnea and respiratory failure, which is a medical emergency known as myasthenic crisis9 . Symptoms vary widely, ranging from isolated ocular signs to generalized muscle weakness with respiratory insufficiency8 .
Myasthenia Gravis Types
Myasthenia gravis presents in several forms, classified based on the muscles affected and patient age.
Generalized Myasthenia Gravis
Generalized MG affects multiple muscle groups, including ocular, bulbar, limb, and respiratory muscles5 7. Patients experience widespread muscle weakness that can impair daily activities such as walking, speaking, and breathing12 . Approximately 80% of generalized MG patients test positive for acetylcholine receptor antibodies12 .
Ocular Myasthenia Gravis
Ocular MG is limited to the extraocular muscles, causing symptoms like ptosis and diplopia4 . It affects about 10% to 40% of MG patients12 . Symptoms may mimic other neurological conditions such as stroke or cranial nerve palsies, and thyroid eye disease can be a differential diagnosis6 13. Ocular MG may progress to generalized MG in nearly half of patients within a few years4 8.
Transient Neonatal Myasthenia Gravis
Transient neonatal MG occurs in infants born to mothers with MG due to transplacental transfer of maternal antibodies14 2. Symptoms appear within the first 24 hours of life and include weak sucking, feeding difficulties, weak crying, and floppy limbs12 . This form is usually temporary, resolving within two to three months as maternal antibodies clear from the infant’s circulation14 2.
Myasthenia Gravis Causes
Myasthenia gravis is an autoimmune disorder in which the body's immune system produces antibodies that disrupt communication at the neuromuscular junction, impairing muscle contraction15 16.
Anti-Acetylcholine Receptor Antibodies
The most common cause of MG is the production of autoantibodies against nicotinic acetylcholine receptors (AChR) on the muscle cell surface15 . These antibodies block, alter, or destroy the receptors, reducing the number of functional receptors available for acetylcholine binding5 . This impairs neuromuscular transmission, leading to muscle weakness and fatigability16 . The antibodies activate the complement system, causing damage to the postsynaptic membrane17 .
Anti-MuSK Antibodies
Some patients produce antibodies against muscle-specific kinase (MuSK), a protein essential for clustering AChRs at the neuromuscular junction15 17. Anti-MuSK antibodies disrupt this process, leading to impaired neuromuscular transmission and muscle weakness13 . MuSK-positive MG may show different clinical features and treatment responses compared to AChR-positive MG17 .
Overactive Thymus Gland
The thymus gland, part of the immune system, plays a role in MG pathogenesis. In many adults with MG, the thymus is abnormally large or contains tumors called thymomas2 . The thymus may produce or support the production of autoantibodies against AChR2 . Approximately 10% of MG patients have thymomas, which are usually benign but may require surgical removal2 5. Thymic hyperplasia (enlargement) is common in younger patients1 .
Diagnosing Myasthenia Gravis
Diagnosing MG involves clinical evaluation and specialized tests to confirm impaired neuromuscular transmission and detect autoantibodies5 7.
Key diagnostic methods include:
- Clinical examination: Assessment of muscle strength, fatigability, and reflexes7
- Serological testing: Detection of anti-AChR and anti-MuSK antibodies in blood; some patients are seronegative16
- Electrophysiological studies: Repetitive nerve stimulation and single-fiber electromyography (EMG) detect impaired neuromuscular transmission5
- Ice pack test: A simple bedside test for ocular MG where cooling improves ptosis temporarily13
- Imaging: Chest CT or MRI to detect thymoma or thymic hyperplasia5
- Edrophonium test: Transient improvement in muscle strength after administration supports diagnosis but is less commonly used now16
Because MG symptoms overlap with other neuromuscular disorders, nerve conduction studies help exclude alternative diagnoses7 .
Myasthenia Gravis Complications
MG can lead to serious complications, especially if untreated or during exacerbations.
- Myasthenic crisis: A life-threatening exacerbation causing severe weakness of respiratory and bulbar muscles, leading to respiratory failure18 3
- Respiratory failure: May require intubation and mechanical ventilation during crisis18
- Thymoma: Tumors of the thymus gland may cause local symptoms and require surgery5
- Medication side effects: Long-term immunosuppressive therapy can cause infections and other adverse effects7
- Misdiagnosis: MG’s fluctuating symptoms and similarity to other disorders make diagnosis challenging7
Triggers for myasthenic crisis include infections, surgery, medication changes, and stress18 . Approximately 10-20% of MG patients experience at least one crisis during their disease course3 .
Myasthenia Gravis Treatment Options
Treatment aims to improve muscle strength, reduce symptoms, and prevent complications. Therapy is individualized based on severity, muscle groups involved, and patient factors5 .
Symptomatic Treatment
- Cholinesterase inhibitors: Pyridostigmine bromide (Mestinon) is the first-line symptomatic treatment that increases acetylcholine availability at the neuromuscular junction, improving muscle contraction5
- These drugs provide rapid relief of muscle weakness but do not affect the underlying autoimmune process5
Immunosuppressive Treatment
- Used when symptoms persist despite cholinesterase inhibitors5
- Common first-line immunosuppressants include prednisone and azathioprine, which reduce antibody production and immune-mediated damage5
- Second-line agents include mycophenolate mofetil, cyclosporine, and rituximab5
- Immunosuppressive therapy requires careful monitoring due to potential side effects5
Intravenous Immunoglobulins (IVIG)/Plasmapheresis
- Used in severe cases or myasthenic crisis to rapidly reduce circulating autoantibodies5 16
- Plasmapheresis: Removes harmful antibodies from the blood and replaces plasma2
- IVIG: Provides donor antibodies that modulate immune response temporarily2
Surgery
- Thymectomy: Surgical removal of the thymus gland can reduce symptoms and medication needs, especially in patients with thymoma or generalized MG5 2
- Thymectomy may induce remission in about 50% of patients2
- Surgery is generally not recommended for MuSK-positive MG without thymic pathology5
Living With Myasthenia Gravis
MG is a chronic condition with no cure, but most patients maintain a good quality of life with treatment1 . Management includes:
- Regular follow-up to optimize therapy and monitor side effects5
- Avoiding triggers such as infections, stress, and certain medications (e.g., beta-blockers, some antibiotics) 19
- Vaccinations against influenza and pneumococcus to prevent infections that may worsen MG19
- Energy conservation strategies and pacing activities to manage fatigue20
- Wearing medical alert identification to provide critical information during emergencies19
With modern therapies, most people with MG live full, active lives and have a normal life expectancy1 10.
Myasthenia gravis is a lifelong medical condition. Early detection is key to managing this condition. The goal of treatment is to increase general muscle function and prevent swallowing and breathing problems10 .
Myasthenia Gravis FAQs
Q: Can myasthenia gravis be cured?
A: Currently, there is no cure for MG, but effective treatments can control symptoms and improve quality of life1 .
Q: What triggers a myasthenic crisis?
A: Infections, surgery, medication changes, stress, and pregnancy can trigger a crisis, which requires emergency care18 3.
Q: Is MG hereditary?
A: Autoimmune MG is rarely inherited, but congenital and neonatal forms have genetic or maternal antibody causes14 2.
Q: How is MG diagnosed?
A: Diagnosis involves clinical evaluation, antibody testing, electrophysiological studies, and imaging of the thymus5 7.
Q: What lifestyle changes help manage MG?
A: Avoiding triggers, pacing activities, maintaining vaccinations, and using assistive devices as needed can help manage symptoms19 20.
